This Brewer Raises Rare Disease Awareness and Funds Through Beer — And Now He Wants Others to Help
source: shutterstock.com

This Brewer Raises Rare Disease Awareness and Funds Through Beer — And Now He Wants Others to Help

  Six years ago, Jonathan Kowalske's son Mac entered the world - and the family suddenly found themselves thrust into the rare disease community. Soon after birth, Kowalske and his…

Continue Reading This Brewer Raises Rare Disease Awareness and Funds Through Beer — And Now He Wants Others to Help
Adzynma Now FDA-Approved for Congenital Thrombotic Thrombyctopenic Purpura (TTP)
source: pixabay.com

Adzynma Now FDA-Approved for Congenital Thrombotic Thrombyctopenic Purpura (TTP)

As shared by MedScape, the U.S. FDA recently approved the first treatment for people living with congenital thrombotic thrombocytopenic purpura (TTP). Its name? Adzynma. In the past, people with TTP…

Continue Reading Adzynma Now FDA-Approved for Congenital Thrombotic Thrombyctopenic Purpura (TTP)
Family Asks People to Join Bone Marrow Registry After Daughter’s Aplastic Anemia Diagnosis
source: pixabay.com

Family Asks People to Join Bone Marrow Registry After Daughter’s Aplastic Anemia Diagnosis

Give the gift of life this holiday season and consider donating your bone marrow to BeTheMatch. Each year, over 18,000 people are diagnosed with a life-threatening blood condition that could…

Continue Reading Family Asks People to Join Bone Marrow Registry After Daughter’s Aplastic Anemia Diagnosis
Wave Life Science’s New Trial Application is Causing Renewed Excitement Around RNA Editing
source: shutterstock.com

Wave Life Science’s New Trial Application is Causing Renewed Excitement Around RNA Editing

  If Wave Life Sciences’ recently submitted trial application for WVE-006 is approved, it will become the first RNA editing treatment in a clinical development setting. Wave’s CEO, Paul Bolno,…

Continue Reading Wave Life Science’s New Trial Application is Causing Renewed Excitement Around RNA Editing